Leslie Somohano
Optometrist · Coral Gables, FLNPI 1336707082
Payments from drug & device makers
Across 160 payments — averaging $67.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$3K
- Johnson & Johnson Vision Care, Inc.$2K
- Coopervision Inc.$1K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$801
- Dompe US, Inc.$677
- Tarsus Pharmaceuticals, Inc.$568
- plus $3K from 16 others
What the payments were for
- Travel & lodging$1,90918%
- Food & beverage$8,78581%
- Entertainment$1401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 30 | $2,635 |
| Johnson & Johnson Vision Care, Inc. | 35 | $2,231 |
| Coopervision Inc. | 15 | $1,341 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 18 | $801 |
| Dompe US, Inc. | 9 | $677 |
| Tarsus Pharmaceuticals, Inc. | 13 | $568 |
| Alcon | 12 | $539 |
| Sun Pharmaceutical Industries Inc. | 3 | $349 |
| Glaukos Corporation | 1 | $203 |
| LKC Technologies, Inc. | 2 | $175 |
| AbbVie | 4 | $154 |
| Optos, Inc. | 3 | $140 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $136 |
| Harrow Eye, LLC | 1 | $125 |
| Sight Sciences, Inc. | 1 | $124 |
| Amgen | 1 | $122 |
| Sanofi | 1 | $122 |
| Biotissue Holdings Inc. | 1 | $107 |
| Rxsight Inc | 3 | $98 |
| Novartis | 4 | $95 |
| Visionix USA, Inc | 1 | $47 |
| Apellis Pharmaceuticals, Inc. | 1 | $46 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$2,345
- Acuvue$1,473
- MiSight Contact Lens$866
- Oxervate$500
- MIEBO$362
- CEQUA$349
- ULTRA MULTIFOCAL TORIC$250
- XDEMVY$245
- Photrexa Viscous and Photrexa$203
- LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE)$136
- XIIDRA$125
- VEVYE$125
- OMNI(R) SURGICAL SYSTEM (US)$124
- Rhopressa$122
- Rocklatan$122
- VYZULTA$112
- Prokera$107
- AmnioGraft$107
- VUITY$107
How this compares
$10,835 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 17 | $11,825 |
| Latanoprost | 15 | $176 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $158 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $154 | $11,82517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,166 optometrist providers in Florida.
Other optometrist in Coral Gables
- Michael KynnJacksonville$4.5M
- Christine HalodaJacksonville$3.1M
- Bradley GieddWinter Park$2.5M
- Christopher PearsonLongwood$2.5M
- Mark PerryOrlando$1.6M
- Bryan StamJacksonville Beach$1M
- Oksana SovaJacksonville$841K
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$781K
- Jerry RobbenSt Augustine$663K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.